Research Article

Evaluation of Knowledge Levels on Asthma Medications among Pediatric Specialists and Residents

Volume: 14 Number: 1 February 20, 2026
EN TR

Evaluation of Knowledge Levels on Asthma Medications among Pediatric Specialists and Residents

Abstract

Background/Objectives: Asthma is the most common chronic respiratory disease in childhood, with a rising prevalence both worldwide and in Türkiye. Around 70–80% of pediatric asthma cases are allergic. Despite the presence of established guidelines, knowledge gaps and practice inconsistencies remain. This study aimed to compare the knowledge levels of pediatric specialists and residents regarding asthma treatment. Methods: This cross-sectional study was conducted in February–March 2025 at the University of Health Sciences Ümraniye Training and Research Hospital. Pediatric specialists and residents completed a 31-item questionnaire based on the 2024 GINA guidelines, including 25 questions on asthma management. Each correct answer was scored as 4 points. Statistical analyses were performed using SPSS 22 with Chi-square/Fisher’s exact tests for categorical and independent t test/Mann–Whitney U for continuous variables. A p value <0.05 was considered significant. Ethical approval was obtained (26.12.2024; no. 470). Results: A total of 53 physicians participated (15 specialists, 38 residents). Specialists had longer experience (≥7 years: 73.3%), whereas most residents had 1–3 years (84.2%). Asthma training was reported more frequently among specialists (86.7% vs. 44.7%). While overall scores were similar, differences emerged: all specialists recognized spacer efficacy (100% vs. 76.3%, p=0.039), whereas residents more often identified omalizumab for allergic asthma (89.5% vs. 53.3%, p=0.003) and budesonide/fluticasone as first-line therapy (94.7% vs. 73.3%, p=0.027). Conclusions: Specialists showed stronger knowledge of inhaler devices, whereas residents were more updated on biologics and pharmacotherapy. Tailored educational strategies may enhance standardized, evidence-based pediatric asthma care.

Keywords

References

  1. 1. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2024 update. Available from: https://ginasthma.org/2024-report/
  2. 2. Brożek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision. J Allergy Clin Immunol. 2017;140(4):950-958.
  3. 3. Aaron SD, Boulet LP, Reddel HK, Gershon AS. Underdiagnosis and overdiagnosis of asthma. Am J Respir Crit Care Med. 2018;198(8):1012-1020.
  4. 4. Oksel C, Custovic A. Development of allergic sensitization and its relevance to paediatric asthma. Curr Opin Allergy Clin Immunol. 2018;18(2):109-116.
  5. 5. Liu AH, Martinez FD, Taussig LM. Natural history of allergic diseases and asthma. In: Leung DYM, Sampson HA, Geha RS, Szefler SJ, eds. Pediatric Allergy. St. Louis: Mosby-Year Book Inc.; 2003. p. 10-22.
  6. 6. Çiçek F. Evaluation of the level of knowledge of pediatricians and assistants about drugs used in the treatment of asthma. Zeynep Kamil Medical Bulletin. 2020 Jan. 1; 51(1):14-8.
  7. 7. Ones U, Akcay A, Tamay Z, Guler N, Zencir M. Rising trend of asthma prevalence among Turkish schoolchildren (ISAAC phases I and III). Allergy 2006;61(12):1448-53.
  8. 8. Bai TR, Vonk JM, Postma DS, Boezen HM. Severe exacerbations predict excess lung function decline in asthma. Eur Respir J. 2007;30(3):452-456.

Details

Primary Language

English

Subjects

Pediatric Immunology and Allergic Diseases

Journal Section

Research Article

Publication Date

February 20, 2026

Submission Date

August 25, 2025

Acceptance Date

February 11, 2026

Published in Issue

Year 2026 Volume: 14 Number: 1

APA
Alkaya, H., Altas, U., Çevik, S., Ünal, G., Altıntaş, T., & Özkars, M. Y. (2026). Evaluation of Knowledge Levels on Asthma Medications among Pediatric Specialists and Residents. Pediatric Practice and Research, 14(1), 1771373. https://doi.org/10.21765/pprjournal.1771373
AMA
1.Alkaya H, Altas U, Çevik S, Ünal G, Altıntaş T, Özkars MY. Evaluation of Knowledge Levels on Asthma Medications among Pediatric Specialists and Residents. pediatr pract res. 2026;14(1):1771373. doi:10.21765/pprjournal.1771373
Chicago
Alkaya, Halil, Ugur Altas, Seda Çevik, Gamze Ünal, Tuğba Altıntaş, and Mehmet Yaşar Özkars. 2026. “Evaluation of Knowledge Levels on Asthma Medications Among Pediatric Specialists and Residents”. Pediatric Practice and Research 14 (1): 1771373. https://doi.org/10.21765/pprjournal.1771373.
EndNote
Alkaya H, Altas U, Çevik S, Ünal G, Altıntaş T, Özkars MY (February 1, 2026) Evaluation of Knowledge Levels on Asthma Medications among Pediatric Specialists and Residents. Pediatric Practice and Research 14 1 1771373.
IEEE
[1]H. Alkaya, U. Altas, S. Çevik, G. Ünal, T. Altıntaş, and M. Y. Özkars, “Evaluation of Knowledge Levels on Asthma Medications among Pediatric Specialists and Residents”, pediatr pract res, vol. 14, no. 1, p. 1771373, Feb. 2026, doi: 10.21765/pprjournal.1771373.
ISNAD
Alkaya, Halil - Altas, Ugur - Çevik, Seda - Ünal, Gamze - Altıntaş, Tuğba - Özkars, Mehmet Yaşar. “Evaluation of Knowledge Levels on Asthma Medications Among Pediatric Specialists and Residents”. Pediatric Practice and Research 14/1 (February 1, 2026): 1771373. https://doi.org/10.21765/pprjournal.1771373.
JAMA
1.Alkaya H, Altas U, Çevik S, Ünal G, Altıntaş T, Özkars MY. Evaluation of Knowledge Levels on Asthma Medications among Pediatric Specialists and Residents. pediatr pract res. 2026;14:1771373.
MLA
Alkaya, Halil, et al. “Evaluation of Knowledge Levels on Asthma Medications Among Pediatric Specialists and Residents”. Pediatric Practice and Research, vol. 14, no. 1, Feb. 2026, p. 1771373, doi:10.21765/pprjournal.1771373.
Vancouver
1.Halil Alkaya, Ugur Altas, Seda Çevik, Gamze Ünal, Tuğba Altıntaş, Mehmet Yaşar Özkars. Evaluation of Knowledge Levels on Asthma Medications among Pediatric Specialists and Residents. pediatr pract res. 2026 Feb. 1;14(1):1771373. doi:10.21765/pprjournal.1771373